CClinicalTrials.gg
CompletedNCT06718114Updated Dec 5, 2024

A Study on Early Removal of Urinary Catheter After Gastric Cancer Surgery Applying ERAS Protocols

An interventional study of immediate urinary catheter removal and early removal of urinary catheter in Urinary Catheter Removal After Surgery, sponsored by Affiliated Hospital of Nanjing University of Chinese Medicine. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Affiliated Hospital of Nanjing University of Chinese Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Dec 2021, registered Nov 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
181
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study compared the immediate removal of urinary catheter and early removal of urinary catheter after radical gastrectomy to explore the feasibility of immediate removal of urinary catheter after radical gastrectomy, especially in the incidence of urinary retention, whether immediate removal is not inferior to early removal.

02

Conditions studied

  • Urinary Catheter Removal After Surgery

Browse trials for

03

In context

Stomach Neoplasms

2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.

This study's enrollment of 181 is above the median of 67 across 2,096 interventional studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Affiliated Hospital of Nanjing University of Chinese Medicine is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • underwent elective radical gastrectomy
  • applied ERAS protocols during perioperative period
  • aged 18~80 years old

Exclusion criteria

Exclusion Criteria:

  • benign prostatic hyperplasia
  • urinary system stones, tumors, strictures, deformities or surgeries
  • pelvic surgery history
  • abnormal preoperative urine routine
  • medication intake that affects urination function
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
181 participants (actual)

Study arms

  • Experimental
    immediate removal of urinary catheter

    The urinary catheter will be removed immediately after surgery.

    Procedure: immediate urinary catheter removal

  • Other
    early removal of urinary catheter

    The urinary catheter will be kept after surgery and be removed within 48 hours after surgery.

    Procedure: early removal of urinary catheter

Interventions

  • Procedureimmediate urinary catheter removal

    Immediate urinary catheter removal indicates that the urinary catheter will be removed immediately after surgery.

  • Procedureearly removal of urinary catheter

    The urinary catheter will be kept after surgery and be removed within 48 hours after surgery.

06

What researchers measure

Primary outcomes

  1. postoperative urinary retention incidence

    Time frame: From urinary catheter removed to 6 hours after removal

Secondary outcomes

  1. postoperative urinary tract infection incidence

    Time frame: from postoperative day 1 to postoperative day 7

  2. anxious status

    measured by Kolcaba scale, Kolcaba scale scores from 30 to 112, higher scores mean the patients feel more comfortable during hospitalization (a better outcome).

    Time frame: postoperative day 1

  3. comfort status

    measured by hospital anxiety and depression scale (HAD scale), HAD scale scores from 0 to 20, a higher score means the patients feel more stressful during hospitalization (a worse result).

    Time frame: postoperative day 1

07

Study locations

1 site
  • Affiliated Hospital of Nanjing University of Chinese Medicine
    Nanjing, Jiangsu 025, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06718114
Lead sponsor
Affiliated Hospital of Nanjing University of Chinese Medicine
Collaborators
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Responsible party
Sponsor
First posted
Dec 5, 2024
Start date
Dec 10, 2021
Primary completion
Jun 20, 2024
Completion
Jun 30, 2024
Last update
Dec 5, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion